Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.330100
-0.0032-0.96%
Pre-Market: 7:49 PM EDT
Comments
Loading...
IGC Pharma (AMEX:IGC) Stock, Analyst Ratings, Price Targets, Forecasts
IGC Pharma Inc has a consensus price target of $3.63 based on the ratings of 2 analysts. The high is $3.75 issued by Ascendiant Capital on September 3, 2024. The low is $3.5 issued by Alliance Global Partners on July 17, 2024. The 3 most-recent analyst ratings were released by Ascendiant Capital, Ascendiant Capital, and Alliance Global Partners on September 3, 2024, July 29, 2024, and July 17, 2024, respectively. With an average price target of $3.58 between Ascendiant Capital, Ascendiant Capital, and Alliance Global Partners, there's an implied 985.53% upside for IGC Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
Alliance Global Partners
1calculated from analyst ratings
Analyst Ratings for IGC Pharma
Data brought to you by Benzinga APIs
FAQ
What is the target price for IGC Pharma (IGC) stock?
The latest price target for IGC Pharma (AMEX:IGC) was reported by Ascendiant Capital on September 3, 2024. The analyst firm set a price target for $3.75 expecting IGC to rise to within 12 months (a possible 1025.11% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IGC Pharma (IGC)?
The latest analyst rating for IGC Pharma (AMEX:IGC) was provided by Ascendiant Capital, and IGC Pharma maintained their buy rating.
When was the last upgrade for IGC Pharma (IGC)?
There is no last upgrade for IGC Pharma
When was the last downgrade for IGC Pharma (IGC)?
There is no last downgrade for IGC Pharma.
When is the next analyst rating going to be posted or updated for IGC Pharma (IGC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IGC Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IGC Pharma was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.
Is the Analyst Rating IGC Pharma (IGC) correct?
While ratings are subjective and will change, the latest IGC Pharma (IGC) rating was a maintained with a price target of $3.50 to $3.75. The current price IGC Pharma (IGC) is trading at is $0.33, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.